EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hyaluronic Acid in Nanopharmaceuticals: An Overview

Sina Matalqah, Zainab Lafi iD, Sara Yousef Asha

Current Issues in Molecular Biology · 20.09.2024 · 46 (9) · 10444-10461

DOI: 10.3390/cimb46090621 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 20.09.2024. Verfasst von Sina Matalqah und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyaluronic acid (HA) is a naturally occurring, long, unbranched polysaccharide that plays a critical role in maintaining skin structure and hydration. Its unique properties make it a valuable component in the field of nanopharmaceuticals. The combination of HA into nanopharmaceuticals enhances its ability to interact with various therapeutic agents, improving the delivery and efficacy of drugs. HA-based nanoparticles, including solid lipid nanoparticles, and polymeric nanogels, offer controlled release, enhanced stability, and targeted delivery of therapeutic agents. These innovations significantly improve therapeutic outcomes and reduce side effects, making HA an essential tool in modern medicine. In general, HA-modified liposomes enhance drug encapsulation and targeting, while HA-modified solid lipid nanoparticles (SLNs) provide a solid lipid core for drug encapsulation, offering controlled release and stability. This article provides an overview of the potential applications and recent advancements of HA in nanopharmaceuticals, emphasizing its significant impact on the evolving field of targeted drug delivery and advanced therapeutic strategies. By delving into the unique properties of HA and its compatibility with various therapeutic agents, this review underscores the promising potential of HA in revolutionizing nanopharmaceuticals.

Schlagwörter

Stichwörter der Autor:innen

hyaluronic acidlubricantnanopharmaceuticalsnanotechnology

Autor:innen und Institutionen

  • Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan.
  • School of Medicine, University of Jordan, Amman 19328, Jordan.

ORCID-Profile: Zainab Lafi

Zitieren

APA

Matalqah, S., Lafi, Z., & Asha, S. Y. (2024). Hyaluronic Acid in Nanopharmaceuticals: An Overview. Current Issues in Molecular Biology, 46(9), 10444-10461. https://doi.org/10.3390/cimb46090621

Vancouver

Matalqah S, Lafi Z, Asha SY. Hyaluronic Acid in Nanopharmaceuticals: An Overview. Current Issues in Molecular Biology. 2024;46(9):10444-10461. doi:10.3390/cimb46090621

BibTeX
@article{Matalqah2024,
  author = {Matalqah, Sina and Lafi, Zainab and Asha, Sara Yousef},
  title = {Hyaluronic Acid in Nanopharmaceuticals: An Overview},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {9},
  pages = {10444--10461},
  doi = {10.3390/cimb46090621}
}
Kostenlos starten →